S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
Log in
NYSE:IVC

Invacare Stock Forecast, Price & News

$9.10
+0.19 (+2.13 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.80
Now: $9.10
$9.27
50-Day Range
$8.58
MA: $9.71
$10.59
52-Week Range
$3.90
Now: $9.10
$10.94
Volume180,500 shs
Average Volume214,792 shs
Market Capitalization$313.20 million
P/E RatioN/A
Dividend YieldN/A
Beta0.94
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Invacare logo

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP46120310
Phone440-329-6000
Employees3,900
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$927.96 million
Cash Flow$0.09 per share
Book Value$8.20 per share

Profitability

Net Income$-53,330,000.00

Miscellaneous

Market Cap$313.20 million
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.62 out of 5 stars

Medical Sector

318th out of 1,962 stocks

Surgical Appliances & Supplies Industry

10th out of 40 stocks

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
$9.10
+0.19 (+2.13 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Invacare (NYSE:IVC) Frequently Asked Questions

Is Invacare a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Invacare stock.
View analyst ratings for Invacare
or view top-rated stocks.

What stocks does MarketBeat like better than Invacare?

Wall Street analysts have given Invacare a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Invacare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Invacare
.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) posted its quarterly earnings results on Tuesday, February, 9th. The health services provider reported ($0.10) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.20) by $0.10. Invacare had a negative trailing twelve-month return on equity of 8.76% and a negative net margin of 4.87%.
View Invacare's earnings history
.

How has Invacare's stock price been impacted by COVID-19 (Coronavirus)?

Invacare's stock was trading at $6.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, IVC shares have increased by 50.4% and is now trading at $9.10.
View which stocks have been most impacted by COVID-19
.

What guidance has Invacare issued on next quarter's earnings?

Invacare issued an update on its FY 2021 After-Hours earnings guidance on Wednesday, February, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $882.336-907.788 million, compared to the consensus revenue estimate of $892.69 million.

What price target have analysts set for IVC?

2 brokerages have issued twelve-month price targets for Invacare's shares. Their forecasts range from $11.00 to $17.00. On average, they anticipate Invacare's stock price to reach $14.00 in the next year. This suggests a possible upside of 53.8% from the stock's current price.
View analysts' price targets for Invacare
or view top-rated stocks among Wall Street analysts.

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 53, Pay $1.89M)
  • Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 58, Pay $731.07k)
  • Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel, Chief Admin. Officer & Sec. (Age 63, Pay $807.32k)
  • Mr. Ralf A. Ledda, Sr. VP & GM of EMEA (Age 53, Pay $608.2k)
  • Lois Lee, Director of Treasury and Investor Relations
  • Mr. Joost Beltman, Sr. VP & GM of North America
  • Ms. Angie Goodwin, Chief Information Technology Officer

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare CEO Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among Invacare's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Invacare's key competitors?

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.25%), Renaissance Technologies LLC (6.91%), Dimensional Fund Advisors LP (6.68%), Paradigm Capital Management Inc. NY (5.74%), Pura Vida Investments LLC (4.81%) and Barrow Hanley Mewhinney & Strauss LLC (4.53%).
View institutional ownership trends for Invacare
.

Which major investors are selling Invacare stock?

IVC stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., North Run Capital LP, Barrow Hanley Mewhinney & Strauss LLC, Royce & Associates LP, JPMorgan Chase & Co., Dimensional Fund Advisors LP, Boston Partners, and Boston Partners.
View insider buying and selling activity for Invacare
or view top insider-selling stocks.

Which major investors are buying Invacare stock?

IVC stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Renaissance Technologies LLC, Paradigm Capital Management Inc. NY, Punch & Associates Investment Management Inc., Plaisance Capital LLC, Public Employees Retirement System of Ohio, Krensavage Asset Management LLC, and Nuveen Asset Management LLC.
View insider buying and selling activity for Invacare
or or view top insider-buying stocks.

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $9.10.

How much money does Invacare make?

Invacare has a market capitalization of $313.20 million and generates $927.96 million in revenue each year. The health services provider earns $-53,330,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis.

How many employees does Invacare have?

Invacare employs 3,900 workers across the globe.

What is Invacare's official website?

The official website for Invacare is www.invacare.com.

Where are Invacare's headquarters?

Invacare is headquartered at ONE INVACARE WAY, ELYRIA OH, 44036.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.